Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases Platform trials can address more than one clinical research question simultaneously and allow for the addition or removal of arms over time. The scien…

A recent article published in Contemporary Clinical Trial Communications evaluates the considerations raised during the regulatory & ethics review of five ID #PlatformTrials: #ECRAIDPrime, #RECLAIM, #REMAPCAP, #RECOVERY, and #SNAP.

Explore the full article here bit.ly/4v0qSCH

#TrialInnovation

George Picard @leedsctru.bsky.social shares insights from CONCORDE — how platform trial designs are reshaping our monitoring approaches.

#PlatformTrials #UKCRC #UKCTUNetork

#Denmark’s life science strategy calls for EU focus on #platformtrials Rigshospitalet in Copenhagen, currently conducting #platformtrials in areas such as blood cancer and dialysis, has established a competence hub to support doctors and researchers in adopting the innovative trial model.

#Denmark’s life science strategy calls for EU focus on #platformtrials

👏🏻 Nice to continue seeing the impact from the EU-PEARL project 2 years later!

@ihieurope.bsky.social #PPP #platformtrials #MDD #innovation

Yesterday our #EPISeminar continued with the third lecture - Thank you very much, @BenjaminHofner, for a fantastic presentation on #PlatformTrials, innovative designs, the combination research with regulatory considerations and the subsequent discussion.

The PROTECT-V platform - RENALISM no more? — NephJC This week on NephTrials we will discuss the PROTECT-V trial, a platform trial for preventing COVID-19 infections in the vulnerable kidney populations.

On Monday we discussed the topic of platform trials with the discussion anchored by the PROTECT-V trial

Touching upon #COVID #PlatformTrials and #Renalism

This was the #NephTrials initiative - a joint NephJC - ISN project

www.nephjc.com/news/protect-v